Taysha Gene Therapies (TSHA) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.09
-0.08
-0.08
-0.07

Details

Expected EPS
-0.0891
Actual EPS
-0.09
Surprise EPS
-0
Surprise Percent
+1.01%

Description

Taysha Gene Therapies (TSHA) has reported earnings of -0.09 per share for Q4 2025.

0 Comments

Share your thoughts